ELMIRON DIN 02029448
Health Canada record
| Active ingredient(s) | PENTOSAN POLYSULFATE SODIUM 100 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C05BA04 PENTOSTAN POLYSULFATE SODIUM |
| Original market date | 31-Dec-1993 |
| Current status date | 13-Feb-2003 |
| Source | Health Canada DPD |
Establishment licence of the holder
Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PENTOSAN POLYSULFATE SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02082101 | CARTROPHEN VET INJ.SC 100MG/ML | BIOPHARM AUSTRALIA PTY LTD. | Solution | PENTOSAN POLYSULFATE SODIUM 100 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 765 | 2002-05-01 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 3116 | 1998-10-06 | New Drug Submission (NDS) | |
| 3134 | 1998-01-19 | New Drug Submission (NDS) |
International API supply for PENTOSAN POLYSULFATE SODIUM
8 active FDA Drug Master Files.
Request a quote for ELMIRON